Tatva Chintan Pharma Chem Limited Financial Ratios
TATVA · Chemicals · Current price ₹1,932.3
P/E ratio
107.5x
P/B ratio
5.0x
ROE
5.4%
ROCE
6.6%
Debt / Equity
0.15
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 107.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 5.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 6.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.15 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Tatva Chintan Pharma Chem Limited's latest numbers.
Tatva Chintan Pharma Chem Limited profitability
Tatva Chintan Pharma Chem Limited generates a return on equity of 5.4% and a return on capital employed of 6.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.15 and a P/E of 107.5x, Tatva Chintan Pharma Chem Limited is conservatively financed. Our overall business-quality score for the company is 3.3 / 10.
Understand the ratios
More on Tatva Chintan Pharma Chem Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.